Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.48 USD | +4.39% | -.--% | -6.75% |
Apr. 30 | Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 | CI |
Apr. 30 | Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- 1801 Stock
- IVBIY Stock
- News Innovent Biologics, Inc.
- Official Publications